Showing 1 - 2 results of 2 for search 'Scott M Palmer', query time: 0.01s Refine Results
  1. 1
    Risk of Atherosclerotic Cardiovascular Disease After Chronic Obstructive Pulmonary Disease Hospitalization among Primary and Secondary Prevention Older Adults

    Risk of Atherosclerotic Cardiovascular Disease After Chronic Obstructive Pulmonary Disease Hospitalization among Primary and Secondary Prevention Older Adults by Christopher L. Mosher, Oyomoare L. Osazuwa‐Peters, Michael G. Nanna, Neil R. MacIntyre, Loretta G. Que, Scott M. Palmer, W. Schuyler Jones, Emily C. O'Brien

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)

    Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial... by Jeffrey J Swigris, Toby M Maher, Tamera J Corte, Aryeh Fischer, Hong Xiao, Lisa Lancaster, Takafumi Suda, Xiaojiang Zhan, Jonathan G Goldin, Scott M Palmer, Hideaki Watanabe, Takashi Ogura, Anne Minnich, Giridhar S Tirucherai, Brandon Elpers, R Adam Smith, Edgar D Charles

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: